Zeramal, the anti-malarial drug of KCH Consumer Healthcare Limited has been recognised as the premium brand of the year 2018 by the Institute of Brand Management of Nigeria (IBMN).
The anti-malarial was recently distinguished among many during the IBMN organised award presentation and investiture ceremony held at Sheraton Hotels and Towers, Ikeja – Lagos.
The organisers of the annual event explained that Zeramal was recognised for its efficacy in the effective treatment of uncomplicated malaria among millions of Nigerians who make use of the product.
“The award was conferred on deserving companies as well as brands and individuals who have made impacts on the lives of consumers through their innovations, inventions and ideas,” said Mr. Desmond Esorougwe, IBMN Registrar/ Chief Executive Officer in his remarks at the occasion.
According to him, as the competitive environment becomes increasingly hostile, strong brand building and branding will be required to thrive and succeed. He added that branding has become a strategic asset and source of competitive advantage for companies.
He further explained that the 2018 edition of the IBMN award was aimed at identifying, recognising and rewarding companies that apply brand culture and brand management best practices to analysing, planning, implementation and control of polices designed to achieve corporate objectives in both profit and non-profit organisations in Nigeria.
The IBMN boss however, commended the awardees for their efforts in seeking high standards in their business operations despite the challenging economic environment; he therefore urged them not to relent.
Speaking to journalists after receiving the award on behalf of the management of the company the Superintendent Pharmacist of KCH Pharm. (Ms.) Oluwaseun Nellie Bastos, expressed gratitude to the organisers for the recognition accorded Zeramal.
She admonished the public to stay on Zeramal anti-malarial ranges in the treatment of uncomplicated malaria because the products meet World Health Organisation’s standards on use of ACTs.
While throwing light on the circulation of some anti-malarial with conflicting dosage composition, the pharmacist said that the public need not be confused about the internationally acceptable dosage regimen for ACTs because Zeramal ranges have addressed the issue. She explained that only 6 tablets of quadruple strength (QS) or 12 tablets of double strength (DS) or 24 tablets normal strength of 20/120 of Arthemether and Lumefantrine combination therapy can effectively treat uncomplicated malaria in adults as recommended by the WHO.
Similarly, Bastos further disclosed: for ages 9-14, the standard dosage regimen is 6 tablets of the Triple Strength (TS) or 18 tablets of the standard of 20/120 Arthemether and Lumefantrine Combination therapy respectively.
“The WHO recommendations must be strictly adhered to and that is what we did with Zeramal ranges,” she said.
Pharm. Bastos who appealed to authorities in NAFDAC to ensure strict compliance to standards in drug labelling by promoters of medicines in the country also urged the public to follow WHO recommended dosage regimen when treating malaria because any treatment of the disease that falls short of internationally acceptable standards leads to resistance by the disease-causing parasite.
It would be recalled that Zeramal ranges had been well received by Nigerians of all ages and drugstores across the country as the effective anti-malarial for treatment of uncomplicated malaria.
Zeramal ranges are packaged as Zeramal QS for adults, Zeramal TS for ages 9-14 years, and Zeramal Dispersible and Zeramal suspension for 6months-8 years.
The ceremony featured award presentations to twenty-five organisations in different categories such as: food brand of the year award, table water of the year award, and biscuit brand of the year award.
Other categories of awards were: cooking oil of the year award, fast food, noodle/pasta, toothpaste, restaurant, automobile and cereal brand of the year.
Similarly, fifty-five marketing practitioners were conferred with Fellow of the Institute; prominent among them was the Chairman of Brand Journalists Association of Nigeria, Mr. Goddies Ofose.